v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
| Column | Value |
|---|---|
| Trial registration number | NCT05252468 |
|
Full text link
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
|
|
First author
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
|
|
Contact
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
Not reported |
|
Registration date
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
2022-02-23 |
|
Recruitment status
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
Completed |
|
Study design
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
RCT |
|
Allocation
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
Randomized |
|
Design
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
Parallel |
|
Masking
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
Blind label |
|
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
single-center |
|
Study aim
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
Prevention |
|
Inclusion criteria
Last imported at : March 12, 2022, midnight Source : ClinicalTrials.gov |
inclusion criteria: subjects 12 yr and older who had not previously been infected with covid-19 to the best of their knowledge. were not vaccinated yet against covid-19 and will not be vaccinated during the study (if they decide to get the vaccine during the study they will be excluded a week later). negative serology rapid test to covid-19. be informed of the nature of the study and the procedures and sign an informed consent form. willing and able to adhere to protocol requirements. if female of childbearing potential, agree to use an acceptable method of birth control or be surgically sterile, and have a negative pregnancy test. |
|
Exclusion criteria
Last imported at : March 12, 2022, midnight Source : ClinicalTrials.gov |
known sensitivity to citric acid and/or sodium citrate and /or benzalkonium chloride and /or hydroxypropylmethylcellulose (hpmc) or lactose (does not mean diagnosed lactose intolerance in food). females who are pregnant or are lactating as reported by the subject. |
|
Number of arms
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
2 |
|
Funding
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
Nasus Pharma |
|
Inclusion age min
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
12 |
|
Inclusion age max
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
120 |
|
Countries
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
Bulgaria |
|
Type of patients
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
Healthy volunteers |
|
Severity scale
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
N/A |
|
Total sample size
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
693 |
|
primary outcome
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
COVID-19 new cases |
|
Notes
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
None |
|
Phase
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
Not reported |
|
Arms
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 2174, "treatment_name": "Taffix", "treatment_type": "Medical device", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}] |